ArticleOncology letters2017

Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.

Hideyuki Ohzawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.